Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene

Journal of Nuclear Medicine

Volumn 46, Issue 5, 2005, Pages 745-751

  Van Dyck, Christopher H ^a,b   Malison, Robert T ^a   Jacobsen, Leslie K ^a,b   Seibyl, John P ^a,b   Staley, Julie K ^a,b   Laruelle, Marc ^a,b   Baldwin, Ronald M ^a,b   Innis, Robert B ^a,b   Gelernter, Joel ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

123I CIT; Dopamine transporter; Genotype; SPECT; VNTR

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123; PROTEIN SLC6A3; UNCLASSIFIED DRUG; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEMBRANE PROTEIN; MICROSATELLITE DNA; NERVE PROTEIN; RADIOPHARMACEUTICAL AGENT; SLC6A3 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VARIABLE NUMBER OF TANDEM REPEAT; ADOLESCENT; AGING; CLINICAL TRIAL; CORPUS STRIATUM; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENETICS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; COCAINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSATELLITE REPEATS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 20644470957     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cook EH, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56:993-998.
2. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 1997;2:311-313.
3. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry. 1999;4:192-196.
4. Waldman ID, Rowe DC, Abramowitz A, et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet. 1993;63:1767-1776.
5. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology. 1994;11:195-200.
6. Sander T, Harms H, Podschus J, et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry. 1997;41:299-304.
7. 9 allele of the dopamine transporter gene. Am J Psychiatry. 1998;155:474-478.
8. Franke P, Schwab SG, Knapp M, et al. DAT1 gene polymorphism in alcoholism a family based association study. Biol Psychiatry. 1999;45:652-654.
9. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999;18:14-20.
10. Sabol SZ, Nelson ML, Fisher C, et al. A genetic association for cigarette smoking behavior. Health Psychol. 1999;18:7-13.
11. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry. 1993;34:265-267
12. Persico AM, Catalano M. Lick of association between dopamine transporter gene polymorphisms and delusional disorder. Am J Med Genet. 1998;81:163-165.
13. Byerley W, Coon H, Hoff M, et al. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees. Hum Hered. 1993;43:319-322.
14. Gelernter J, Vandenbergh D, Kruger SD, et al. The dopamine transporter protein gene (SLC6A3): primary linkage mapping and linkage studies in Tourette syndrome. Genomes. 1995;30:459-463
15. Vandenbergh DJ, Thompson MD, Cook EH, et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry. 2000;5:283-292.
16. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem. 2001;79:1033-1038.
17. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 2001;1:152-156.
18. Miller GM, Madras BK. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry. 2002;7:44-55.
19. Heinz A, Goldman D, Jones DW, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 2000;22:133-139.
20. Jacobsen LK, Staley JK, Zoghbi SS, et al. Prediction of dopamine transporter binding availability by genotype a preliminary report. Am J Psychiatry. 2000;157:1700-1703.
21. Martinez D, Gelernter J, Abi-Dargham A, et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology. 2001;24:553-560.
22. Lynch DR, Mozley PD, Sokol S, Maas NMC, Balcer LJ, Siderowf AD. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord. 2003;18:804-812.
23. Folstein MF, Fostein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
24. 123I]β-CIT SPECT. Neurobiol Aging. 2000;21:497-501.
25. van Dyck CH, Seibyl JP, Malison RT, et al. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry. 2002;10:36-43.
26. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab. 1994;14:982-994.
27. Seibyl JP, Laruelle M, van Dyck CH, et al. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. J Nucl Med. 1996;37:222-228.
28. 123I]β-CIT SPECT. J Nucl Med. 1995;36:1175-1181.
29. Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics. 1992;14:1104-1106.
30. Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao J. Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol. 1995;12:303-308.
31. Gelernter J, Kranzler H, Lacobelle J. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), μ opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics. 1998;52:289-297.
32. Volkow ND, Ding Y-S, Fowler JS, et al. Dopamine transporters decrease with age. J Nucl Med. 1996;37:554-559.
33. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol. 1995;38:589-598.
34. 123I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem. 1994;62:549-555.
35. Rajeevan N, Zubal IG, Ramsby SQ, Zoghbi SS, Seibyl J, Innis RB. Significance of nonuniform attenuation collection in quantitative brain SPECT imaging. J Nucl Med. 1998;39:1719-1726.
36. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 1999;354:2132-2133.
37. 99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med. 2000;27:1518-1524.
38. Volkow ND, Sanders M, Wang GJ, et al. Brain dopamine transporters and D2 receptors in never medicated adults with ADHD [abstract]. J Nucl Med. 2002;43(suppl):16P.
39. van Dyck CH, Quinlan DM, Cretella LW, et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry. 2002;159:309-312.
40. 123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology. 2001;57:2089-2094.